Asset Details
Do you wish to reserve the book?
SP1 regulates BMSC osteogenic differentiation through the miR-133a-3p/MAPK3 axis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
SP1 regulates BMSC osteogenic differentiation through the miR-133a-3p/MAPK3 axis
Do you wish to request the book?
SP1 regulates BMSC osteogenic differentiation through the miR-133a-3p/MAPK3 axis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
SP1 regulates BMSC osteogenic differentiation through the miR-133a-3p/MAPK3 axis
2024
Overview
Background
The progression of osteoporosis (OP) can dramatically increase the risk of fractures, which seriously disturb the life of elderly individuals. Specific protein 1 (SP1) is involved in OP progression. However, the mechanism by which SP1 regulates OP progression remains unclear.
Objective
This study investigated the mechanism underlying the function of SP1 in OP.
Methods
SAMP6 mice were used to establish an in vivo model of age-dependent OP, and BALB/c mice were used as controls. BMSCs were extracted from two subtypes of mice. Hematoxylin and eosin staining were performed to mark the intramedullary trabecular bone structure to evaluate histological changes. ChIP assay was used to assess the targeted regulation between SP1 and miR-133a-3p. The binding sites between MAPK3 and miR-133a-3p were verified using a dual-luciferase reporter assay. The mRNA levels of miR-133a-3p and MAPK3 were detected using quantitative reverse transcription polymerase chain reaction (RT-qPCR). The protein expression of SP1, MAPK3, Colla1, OCN, and Runx2 was examined using Western blotting. Alkaline phosphatase (ALP) kit and Alizarin Red S staining were used to investigate ALP activity and mineralized nodules, respectively.
Results
The levels of SP1 and miR-133a-3p were upregulated, whereas the expression of MAPK3 was downregulated in BMSCs from SAMP6 mice, and miR-133a-3p inhibitor accelerated osteogenic differentiation in BMSCs. SP1 directly targeted miR-133a-3p, and MAPK3 was the downstream mRNA of miR-133a-3p. Mechanically, SP1 accelerated osteogenic differentiation in BMSCs via transcriptional mediation of the miR-133a-3p/MAPK3 axis.
Conclusion
SP1 regulates osteogenic differentiation by mediating the miR-133a-3p/MAPK3 axis, which would shed new light on strategies for treating senile OP.
Publisher
BioMed Central
Subject
/ Cell Differentiation - genetics
/ Cell Differentiation - physiology
/ Male
/ Medicine
/ Mesenchymal Stem Cells - metabolism
/ Mice
/ Mitogen-Activated Protein Kinase 3 - genetics
/ Mitogen-Activated Protein Kinase 3 - metabolism
/ Sp1 Transcription Factor - genetics
